123/125I-labelled 2-iodo-L-phenylalanine and 2-iodo-D-phenylalanine: Comparative uptake in various tumour types and biodistribution in mice

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 33, Issue 8, 2006, Pages 919-927

  Kersemans, Veerle ^a   Cornelissen, Bart ^a   Kersemans, Ken ^b   Bauwens, Matthias ^b   Dierckx, Rudi A ^c   De Spiegeleer, Bart ^a   Mertens, John ^b   Slegers, Guido ^a  

^a GHENT UNIVERSITY   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

123I 2 iodo phenylalanine; D amino acid; Radiolabelled amino acids; Tracer evaluation; Tumour imaging

Indexed keywords

2 IODO DEXTRO PHENYLALANINE I 123; 2 IODO DEXTRO PHENYLALANINE I 125; 2 IODOPHENYLALANINE I 123; 2 IODOPHENYLALANINE I 125; AMINO ACID DERIVATIVE; RADIOPHARMACEUTICAL AGENT; TRACER; UNCLASSIFIED DRUG; 4 IODOPHENYLALANINE; 4-IODOPHENYLALANINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; PHENYLALANINE;

ANIMAL EXPERIMENT; ARTICLE; CLEARANCE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISSECTION; DRUG UPTAKE; FEMALE; HUMAN; HUMAN CELL; IMAGING; ISOTOPE LABELING; MOUSE; NONHUMAN; NUDE MOUSE; RADIATION DOSE; RADIOISOTOPE DISTRIBUTION; TRANSPORT KINETICS; TUMOR; TUMOR CELL LINE; TUMOR DIAGNOSIS; ANIMAL; ANTIBODY SPECIFICITY; CARCINOMA; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE DISTRIBUTION;

ANIMALS; CARCINOMA; CELL LINE, TUMOR; FEMALE; HUMANS; ISOTOPE LABELING; METABOLIC CLEARANCE RATE; MICE; ORGAN SPECIFICITY; PHENYLALANINE; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33746390628     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-005-0043-9     Document Type: Article

References (20)

1. 18F-FDG. J Nucl Med 2003;44:533-539
2. Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA, et al. Radiolabelled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 2001;42:432-445
3. Lahoutte T, Mertens J, Caveliers V, Franken PR, Everaert H, Bossuyt A, et al. Comparative biodistribution of iodinated amino acids in rats: selection of the optimal analog for oncologic imaging outside the brain. J Nucl Med 2003;44:1489-1494
4. Isselbacher KJ. Sugar and amino acid transport by cells in culture - differences between normal and malignant cells. Seminars in Medicine of the Beth Israel Hospital 1972;286:929-933
5. 14C]-tyrosine. Nucl Med Commun 2001;22:87-96
6. 11C-labeled D-amino acids into tumor bearing animals. Gann 1978;69:517-523
7. Yanagida O, Kanai Y, Chairoungdua A, Kim DK, Segawa H, Nii T, et al. Human L-type amino acid transport system 1 (LAT1): characterisation of function and expression in tumour cell lines. Biochim Biophys Acta 2001;1514:291-302
8. Tyr deacylase: stereospecificity of the translation machine revisited. FEBS Letters 2003;552:95-98
9. Kersemans B, Cornelissen K, et al. In Vivo Characterization of 123/1251-2-iodo-LPhenylalanine in an RIM Rhabdomyosarcoma Athymic Mouse Model as a Potential Tumor Tracer for SPECT. J Nucl Med 2005;46:532-539
10. Kersemans V, Kersemans K, Cornelissen B, et al. In vivo evaluation of [I-123]-2-iodo-D-phenylalanine in tumour inoculated athymic mice by means of SPECT as a potential diagnostic and radionuclide therapy tool. Eur J Nucl Med 2004;31:S219 (meeting abstract)
11. Shotwell MA, Jayme DW, Kilberg MS, Oxender DL. Neutral amino acid transport systems in Chinese hamster ovary cells. J Biol Chem 1981;256:5422-5427
12. Mertens JJR, Kersemans V, Lahoutte T, Bauwens M, Joos C, Kersemans K, et al. Radioiodo-D-2-I-phenylalanine a new tumour specific tracer for diagnosis and systemic radionuclide therapy. Eur J Nucl Med Mol Imaging 2004;31:S220
13. Waterton JC, Alott CP, Pickfort R, et al. Assessment of mouse tumour xenograft volumes in vivo by ultrasound imaging, MRI and calliper measurement. In: Faulkner K, Carey B, Crellin A, Harrison RM, editors. Proceedings of the 19th LH Gray Conference: Quantitative imaging in oncology. London; 1997 p. 146-149
14. Cornelissen B, Kersemans V, Jans L, Staelens L, Oltenfreiter R, Thonissen T, et al. Comparison between 1 T MRI and non-MRI based volumetry in inoculated tumours in mice. Br J Radiol 2005;78:338-342
15. Thie JA. Understanding the standardized uptake value, its methods and implications for usage. J Nucl Med 2004;45:1431-1434
16. 123I]iodo-alpha-methyl-L- tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 2002;29:625-631
17. Vekeman M, Chavatte K, Lahoutte T, et al. L-[2-radioiodo] tyrosine, a new potential protein synthesis and tumour tracer for SPECT: radio synthesis and biodistribution in rodent [abstract]. Eur J Nucl Med 1999;26:S43
18. 123I]iodo-L-phenylalanine for routine brain tumor imaging. Nucl Med Commun 2002;23:121-130
19. Samnick S, Richter S, Romeike BF, Heimann A, Feiden W, Kempski O, et al. Investigation of iodine-123-labelled amino acid derivatives for imaging cerebral gliomas: uptake in human glioma cells and evaluation in stereotactically implanted C6 glioma rats. Eur J Nucl Med 2000;27:1543-1551
20. Keyaerts M, Lahoutte T, Everaert H, et al. Initial clinical evaluation of 123-I-2-iodo-tyrosine in patients with brain tumours. (meeting abstract EANM 2005, Istanbul)